Niki BioSolutions (NIKI) EBITDA Margin (2024)
Niki BioSolutions (NIKI) posted EBITDA Margin of -280.23% for FY2025.
Powered by 
Analysis
Niki BioSolutions (NIKI) EBITDA Margin (2024) Analysis & Trends
Since FY2022, Niki BioSolutions has reported EBITDA Margin for 4 years.
- Annual EBITDA Margin shows a three-year change of -1830.71 percentage points (FY2022 to FY2025).
- Business Quant data shows NIKI's EBITDA Margin at -30.77% in FY2024, 2849.35% in FY2023 (+1298.86 pp) and 1550.49% in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Niki BioSolutions | 1.04 Mn | 801,227.08 | - | - |
API Access
Niki BioSolutions EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NIKI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NIKI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NIKI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();